O. Pate

Statistics

Publications

Citations

686

H-Index

Active since

1994

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Lymphoma Research Foundation

O. Pate is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, chemotherapy, and chemotherapy in hematologic malignancies.

Publications per year

1994–2004

Publications

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.

Peter McLaughlin, Fredrick B. Hagemeister, Jorge Romaguera et al. · Journal of Clinical Oncology · 1996 · 263 citations

Medicine, Pharmacology, Pharmacotherapy +13

Liposomal vincristine in relapsed non-Hodgkin's lymphomas: Early results of an ongoing phase II trial

A H Sarris, Frederick Hagemeister, Jorge Romaguera et al. · Annals of Oncology · 2000 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.

Peter McLaughlin, Fredrick B. Hagemeister, F Swan et al. · Journal of Clinical Oncology · 1994 · 93 citations

Medicine, Oncology, Pharmacology +15

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma.

Paul McLaughlin, Fredrick B. Hagemeister, Maria Alma Rodriguez et al. · PubMed · 2000 · 70 citations

Medicine, Oncology, Pharmacotherapy +12

Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: High remission rates and reversion to negative of peripheral blood bcl-2 rearrangement

Peter McLaughlin, F.B. Hagmeister, F Swan et al. · Annals of Oncology · 1994 · 43 citations

Medicine, Hematology, Oncology +13

1–5 of 9